Great Waters Wealth Management Has $388,000 Position in Solventum Co. (NYSE:SOLV)

Great Waters Wealth Management trimmed its position in shares of Solventum Co. (NYSE:SOLV) by 5.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,872 shares of the company’s stock after selling 318 shares during the quarter. Great Waters Wealth Management’s holdings in Solventum were worth $388,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. American Century Companies Inc. acquired a new stake in Solventum in the second quarter valued at $6,699,000. Envestnet Asset Management Inc. acquired a new stake in shares of Solventum in the second quarter valued at about $6,747,000. Dimensional Fund Advisors LP bought a new position in shares of Solventum during the second quarter worth about $26,480,000. Mutual of America Capital Management LLC acquired a new position in shares of Solventum in the second quarter worth approximately $920,000. Finally, Mercer Global Advisors Inc. ADV bought a new stake in Solventum in the second quarter valued at approximately $730,000.

Analyst Ratings Changes

Several research firms have issued reports on SOLV. Piper Sandler boosted their price target on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Wolfe Research initiated coverage on shares of Solventum in a research note on Thursday, September 26th. They set a “peer perform” rating for the company. Stifel Nicolaus started coverage on shares of Solventum in a research report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price target on the stock. Mizuho started coverage on Solventum in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price objective for the company. Finally, Morgan Stanley upped their target price on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. One analyst has rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Solventum has an average rating of “Hold” and an average price target of $68.29.

Solventum Stock Performance

SOLV stock opened at $73.60 on Tuesday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The company’s 50-day moving average is $69.16 and its 200-day moving average is $65.85. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.